IMvigor130 data: atezolizumab alone or with chemo upfront for bladder cancer
Thomas Powles • 29 Sep 2019
Savolitinib plus durvalumab show promise in papillary renal cancer: CALYPSO results
Using checkpoint inhibitors at earlier stages of bladder cancer – the next step in immunotherapy?
Thomas Powles • 25 Mar 2017